Direct-to-Patient Telehealth and Pharmacy MVP for a Specialty Pharma
Let's Connect
Problem
First direct-to-patient channel launch
A mid-size specialty pharma was launching its first direct-to-patient channel — telehealth consultations and home-delivery pharmacy across 14 states — with no consumer-facing engineering capability in house. Internal estimates put a full platform at eighteen months, the executive team wanted a launch within two quarters, and every state carried its own telehealth and pharmacy rules that had to hold from day one.
Solution
Sixteen-week compliant MVP
We scoped and delivered the MVP in sixteen weeks: a patient intake and eligibility flow driven by state-aware rules, scheduling and video consultations through an independent clinician network's API, e-prescription hand-off to a licensed fulfilment pharmacy partner, and order tracking on HIPAA-aligned infrastructure. Native apps and loyalty features were deliberately deferred to post-launch releases.
Measurable Impact
What changed after launch
MVP live in all 14 target states within 16 weeks, against an 18-month internal build estimate
74% of eligible patients completed intake through to a booked consultation in a single session
Median time from completed intake to shipped first prescription held under 72 hours across the launch quarter
11 state-rule updates shipped in the first quarter through the configuration-driven rules engine, without a code release
Tech & Tools Used
What powered the build
Ready to Build your Pharma & Life Sciences Business with MVP Development
Ask Byte
Ask Byte
Typically replies instantly
just Now
Hi! I'm OrganByte's assistant. How can I help you today?
AI-generated content may be incorrect
